0001193125-26-059602
SEC filingGentherm Incorporated reported product revenues of $1.50 billion for fiscal year 2025, with a gross margin of $362.2 million. Operating income was $82.7 million, but net income declined to $18.3 million due to significant foreign currency losses of $28.4 million, impairment charges totaling $22.0 million, and restructuring expenses of $12.5 million. The company generated $116.8 million in operating cash flow and ended the year with $160.8 million in cash and cash equivalents. Total assets stood at $1.40 billion, with total liabilities of $676.1 million and shareholders' equity of $720.3 million. Earnings per share were $1.00 for both basic and diluted calculations. The company's financial performance was impacted by non-operating items including foreign exchange volatility and asset impairments.
Gentherm Incorporated reported product revenues of $1.50 billion for fiscal year 2025. The company achieved a gross margin of $362.2 million, representing a 24.1% gross margin rate. Operating income was $82.7 million, but net income declined to $18.3 million due to significant foreign currency losses of $28.4 million, impairment charges totaling $22.0 million (including $19.5 million goodwill impairment and $2.5 million impairment of intangible assets and property), and restructuring expenses of $12.5 million. Earnings per share were $1.00 for both basic and diluted calculations. The company generated $116.8 million in operating cash flow and ended the year with $160.8 million in cash and cash equivalents.
The filing reports product revenues of $1.50 billion for FY 2025. No segment breakdown, geographic mix, or specific growth drivers are disclosed in the provided data. The revenue figure represents total product revenues without further categorization by business segment, product line, or geographic region. The absence of segment data in the provided financial statements suggests the company may operate as a single reporting segment or that segment details are not included in the extracted XBRL data.
Gross margin was $362.2 million on $1.50 billion in revenue, representing a 24.1% gross margin. Operating margin was 5.5% with operating income of $82.7 million. The cost structure included cost of sales of $1.14 billion, research and development expenses of $94.8 million, and selling, general and administrative expenses of $170.0 million. Significant non-operating items impacted profitability, including foreign currency losses of $28.4 million, impairment charges of $22.0 million, and restructuring expenses of $12.5 million. These items reduced earnings before income tax to $35.8 million and net income to $18.3 million.
The company generated $116.8 million in operating cash flow for FY 2025. Free cash flow, calculated as operating cash flow ($116.8M) minus capital expenditures ($55.7M), was $64.4 million. The balance sheet shows total assets of $1.40 billion, including $777.0 million in current assets and $270.6 million in property and equipment. Total liabilities were $676.1 million, with $189.0 million in long-term debt and $404.3 million in current liabilities. Shareholders' equity was $720.3 million, resulting in a debt-to-equity ratio of approximately 0.26. The company maintained a strong liquidity position with $160.8 million in cash and cash equivalents.
The provided financial data does not include management guidance, strategic priorities, or specific risk factors from the filing. No forward-looking statements, outlook commentary, or strategic initiatives are disclosed in the extracted XBRL data or document content. The analysis is limited to the historical financial results for FY 2025 as presented in the financial statements. Investors should refer to the complete 10-K filing for management's discussion and analysis, risk factors, and forward-looking statements that typically accompany these financial results.